International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8360522
Original Article
Role of MRI in Determining Limb Salvage for Musculoskeletal Tumours
 ,
 ,
 ,
 ,
Published
Sept. 17, 2023
Abstract

Background: Musculoskeletal tumors pose significant diagnostic and treatment challenges. Accurate assessment of these tumors is critical for therapeutic decision-making, especially concerning limb salvage surgeries. Magnetic Resonance Imaging (MRI) offers detailed visualization, making it an invaluable tool in the evaluation of the extent and nature of such tumors.

Aims and Objectives: To assess the involvement patterns of bone, periosteal, and soft tissue in musculoskeletal tumors through MRI.

To correlate the findings of operable MRI cases with the results observed during intraoperative procedures.

Methods: After securing ethical committee clearance and informed consent, 60 patients with musculoskeletal tumors were referred to our department for an MRI study. Based on these MRI findings, plans for limb salvage surgeries were coordinated by both surgical oncology and orthopedics teams.

Results: Our cohort study's diagnostic accuracy, sensitivity, and specificity are detailed for each study variable. The mean age of participants was found to be 27.75 +/-14.97 years, with a notable male dominance (Male: Female ratio of 2.5:1). Separate sections elucidate the skeletal distribution, tumor nature, periosteal reactions, articular surface, soft tissue, neurovascular bundles, and intra-medullary involvements observed in our study. The sensitivity, specificity, and diagnostic accuracy of MRI stand at 97.6%, 94.4%, and 70% respectively.

Conclusion: This highlights MRI's pivotal role as the preferred modality in delineating the scope of musculoskeletal tumors, stressing its utility in ascertaining tumor invasion extents and its importance in preoperative evaluations and treatment assessments.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
92 Views
438 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved